Study of tumor and blood markers in gynecologic cancers
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re at least 16 years old and can sign consent in writing
- You have a likely or confirmed gynecologic cancer (such as uterine or cervical), and you’re getting planned surgery or radiation upfront
- You can provide tumor tissue and/or biopsy (if possible) and blood (and sometimes fluid samples)
- Your general health is fairly good (ECOG 0 to 2) and you’re expected to live at least 3 months
- Your cancer has not been treated yet with chemotherapy or radiation for this new diagnosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “biomarkers,” meaning measurable signals in blood and tumor tissue, in people with advanced ovarian-type cancers. The goal is to understand these markers and how they relate to the cancer, which may help guide future care.
This study builds a clinical and biological database for people newly diagnosed with certain cancers. It may help doctors better understand cancer patterns and improve future care, and it involves agreeing to extra blood samples.
This study is looking at people with rare cancers affecting the female reproductive system. It may help researchers learn more about how these cancers behave and how best to follow patients over time.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
This trial is collecting tissue and blood samples from people with rare gynecological cancers, such as unusual ovarian tumors, uterine sarcomas, or vulvar cancer. The goal is to use advanced lab tests (called multi-omics) to learn more about these cancers and improve treatment.
Hear when a new Gynecologic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.